Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study

被引：0

作者：

Busse, William W. ^{[1
]}

Kraft, Monica ^{[2
]}

Domingo, Christian ^{[3
]}

de Mir, Ines ^{[4
]}

Maselli, Diego ^{[5
]}

Xia, Changming ^{[6
]}

Pandit-Abid, Nami ^{[7
]}

Soler, Xavier ^{[8
]}

Jacob-Nara, Juby A. ^{[9
]}

Sacks, Harry ^{[10
]}

Rowe, Paul J. ^{[11
]}

Deniz, Yamo ^{[12
]}

机构：

[1] Univ Wisconsin, Sch Med & Publ Hlth, UW Allergy Pulm & Crit Care Med, Madison, WI 53706 USA

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Univ Autonoma Barcelona, Pulm Serv, Barcelona, Spain

[4] Hosp Valle De Hebron, Pulm Funct Lab, Barcelona, Spain

[5] UT Hlth, San Antonio, TX USA

[6] Regeneron Pharmaceut Inc, Stat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[7] Sanofi, Global Med Affairs, Bridgewater, MA USA

[8] Regeneron Pharmaceut Inc, Dept Med, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[9] Sanofi, Global Med Affairs Resp Allergy & Gastroenterol, Bridgewater, MA USA

[10] Regeneron Pharmaceut Inc, Immunol & Inflammat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[11] Sanofi, Global Med, Immunol, Bridgewater, MA USA

[12] Regeneron Pharmaceut Inc, Global Clin Dev, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

来源：

RESPIROLOGY | 2023年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AO01-1

引用

页码：11 / 12

页数：2

共 50 条

[11] Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
Wechsler, Michael E.
Ford, Linda B.
Maspero, Jorge F.
Pavord, Ian D.
Papi, Alberto
Bourdin, Arnaud
Watz, Henrik
Castro, Mario
Nenasheva, Natalia M.
Tohda, Yuji
Langton, David
Cardona, Guido
Domingo, Christian
Park, Hae Sim
Chapman, Kenneth R.
Mao, Xuezhou
Zhang, Yi
Khan, Asif H.
Deniz, Yamo
Rowe, Paul J.
Kapoor, Upender
Khokhar, Faisal A.
Mannent, Leda P.
Ruddy, Marcella
Laws, Elizabeth
Amin, Nikhil
Hardin, Megan
LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : 11 - 25
[12] LONG-TERM EFFECT OF DUPILUMAB ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 ASTHMA: LIBERTY ASTHMA TRAVERSE STUDY
Papi, Alberto
Castro, Mario
Corren, Jonathan
Pavord, Ian
Tohda, Yuji
Daizadeh, Nadia
Ortiz, Benjamin
Djandji, Michel
Ruddy, Marcella
Laws, Elizabeth
Mannent, Leda
Amin, Nikhil
Gall, Rebecca
Jacob-Nara, Juby
Deniz, Yamo
Rowe, Paul
Lederer, David
Hardin, Megan
CHEST, 2021, 160 (04) : 1854A - 1858A
[13] Impact of early transient increase in eosinophils in patients with moderate-to-severe asthma on the long-term efficacy of dupilumab in TRAVERSE
Pavord, Ian Douglas
Lugogo, Njira L.
Castro, Mario
Papi, Alberto
Bourdin, Arnaud
Wechsler, Michael E.
Cote, Andreanne
Xia, Changming
Soliman, Mena
Pandit-Abid, Nami
Jacob-Nara, Juby A.
Sacks, Harry
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[14] LONG-TERM EFFICACY OF DUPILUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA IN THE LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY: IMPROVEMENTS IN ASTHMA CONTROL AND HEALTH-RELATED QUALITY OF LIFE
Pavord, I. D.
Wechsler, M. E.
Ford, L. B.
Maspero, J. F.
Langton, D.
Domingo, C.
Papi, A.
Bourdin, A.
Watz, H.
Mao, X.
Amin, N.
Hardin, M.
Zhang, Y.
Khan, A. H.
THORAX, 2021, 76 : A91 - A92
[15] Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
Wechsler, Michael
Rogers, Linda
Canonica, Giorgio
Bourdin, Arnaud
Altincatal, Arman
Hardin, Megan
Soler, Xavier
Rowe, Paul
Deniz, Yamo
Sacks, Harry
Jacob-Nara, Juby
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB96 - AB96
[16] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
Tohda, Yuji
Nakamura, Yoichi
Fujisawa, Takao
Ebisawa, Motohiro
Msihid, Jerome
Djandji, Michel
Ortiz, Benjamin
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
Ishida, Masato
Arima, Kazuhiko
ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 89 - 99
[17] Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
Wechsler, Michael E.
Ford, Linda B.
Maspero, Jorge F.
Pavord, Ian D.
Tohda, Yuji
Langton, David
Domingo, Christian
Papi, Alberto
Bourdin, Arnaud
Watz, Henrik
Park, Hae Sim
Chapman, Kenneth R.
Mao, Xuezhou
Ortiz, Benjamin
Djandji, Michel
Kapoor, Upender
Khokhar, Faisal A.
Mannent, Leda P.
Ruddy, Marcella
Laws, Elizabeth
Amin, Nikhil
Hardin, Megan
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[18] LONG-TERM EFFICACY OF DUPILUMAB IN ORAL CORTICOSTEROID-DEPENDENT PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE
Sher, Lawrence
Wechsler, Michael
Rabe, Klaus
Maspero, Jorge
Daizadeh, Nadia
Mao, Xuezhou
Ortiz, Benjamin
Mannent, Leda
Laws, Elizabeth
Ruddy, Marcella
Pandit-Abid, Namrata
Lederer, David
Hardin, Megan
CHEST, 2021, 160 (04) : 1882A - 1884A
[19] Long-Term Efficacy of Dupilumab in Patients With Asthma With an Allergic Phenotype Rolled Over From LIBERTY ASTHMA QUEST: LIBERTY ASTHMA TRAVERSE Study
Sher, Lawrence
Corren, Jonathan
Pavord, Ian
Daizadeh, Nadia
Ortiz, Benjamin
Djandji, Michel
Deniz, Yamo
Rowe, Paul
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB60 - AB60
[20] Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
Rhee, Chin Kook
Park, Jung-Won
Park, Heung-Woo
Noh, Hayeon
Msihid, Jerome
Cho, You Sook
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (04) : 372 - 386

← 1 2 3 4 5 →